catalent glp 1 releases Q1 fiscal results Catalent x Novo: GLP-1 and

The FDA has approved the first oral GLP-1 for weight loss

In practice, this can be seen through prior authorization requirements that often request documentation of such comorbidities, reinforcing their role in determining patient eligibility and access

The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications

Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.

Theyve become some of the most widely discussed

Berberine is a plant alkaloid affecting glucose metabolism at the cellular level, while GLP-1 agonists regulate appetite and insulin secretion through hormone signaling